ORION SANTE SARL
Desconocido
Impentri: Development of Impentri an intravenous imatinib formulation for Covid 19 acute respiratory distress...
ORION SANTE SARL
participó en un
H2020:
H2020-JTI-IMI2-2020-21-single-stage
The accumulation of fluid in the lungs is a significant feature of the pathology in patients with severe Covid-19 infection. This build up o...
2020-08-07 - 2022-10-31 | Financiado
2020-08-07 - 2022-10-31 | Financiado
* No se disponen de datos de la empresa actual.